Clene Inc. (CLNN): Shareholders' Equity
-$17.59M
As of 2025-12-31
-$24.78M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$17.59M | n/m | 2026-03-17, Balance as of period end |
| 2024-12-31 | -$8.86M | n/m | 2026-03-17, Balance as of period end |
| 2023-12-31 | $13.39M | +313.7% | 2025-03-24, Balance as of period end |
| 2022-12-31 | $3.24M | -74.3% | 2024-03-13, Balance as of period end |
| 2021-12-31 | $12.60M | n/m | 2023-03-13, Balance as of period end |
| 2020-12-31 | $341.0K | n/m | 2022-03-11, Balance as of period end |
| 2019-12-31 | -$67.77M | n/a | 2021-03-29, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Clene Inc. (CLNN) | 2025-12-31 | -$17.59M | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $14.86M | -49.8% |
| Regen BioPharma Inc (RGBP) | 2025-09-30 | -$6.28M | n/m |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $11.11M | +806.2% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | -$37.0K | n/m |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $3.76M | n/m |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $9.83M | -16.8% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | -$6.30M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.14M | -57.0% |
Compare CLNN, LSTA, RGBP, ABVC side by side · Screen every company in Pharmaceutical Preparations ↗